Automated Neuromelanin Imaging as a Diagnostic Biomarker for Parkinson's Disease

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 7, 2015-06 ,pp. : 945-952

John Wiley & Sons Inc

Access to resources Recommend Favorite

Assessing the Value-Adding Impact of Diagnostic-Type Tests on Drug Development and Marketing

By Blair Edward D.  

Molecular Diagnosis & Therapy, Vol. 12, Iss. 5, 2008-01 ,pp. : 331-337

Adis International

Access to resources Recommend Favorite

Adding another dimension to plan evaluation: visualising the dose–volume histogram band in head and neck radiotherapy and exploring its utility

By  

Journal of Radiotherapy in Practice, Vol. 16, Iss. 4, 2017-04 ,pp. : 403-408

Cambridge University Press

Access to resources Recommend Favorite

Chronic fatigue syndrome and impaired peripheral pulse characteristics on orthostasis–a new potential diagnostic biomarker

By Allen John   Murray Alan     Newton Julia L  

Physiological Measurement, Vol. 33, Iss. 2, 2012-02 ,pp. : 231-241

IOP Publishing

Access to resources Recommend Favorite

Antibodies against human papillomaviruses as diagnostic and prognostic biomarker in patients with neck squamous cell carcinoma from unknown primary tumor

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 142, Iss. 7, 2018-04 ,pp. : 1361-1368

John Wiley & Sons Inc

Access to resources Recommend Favorite